应交易所要求,美/港股行情延时15分钟展示,下载APP即可免费查看实时行情。
关闭
ICVX Icosavax, Inc.
停牌 07-29 11:00:49 EDT
15.31
+0.00
0.00%
最高
15.31
最低
15.31
成交量
0.00
今开
15.31
昨收
15.31
日振幅
0.00%
总市值
7.78亿
流通市值
4.55亿
总股本
5,080万
成交额
1.43亿
换手率
0.00%
流通股本
2,972万
市净率
3.35
ROE
-42.23%
每股收益
-2.19
52周最高
16.11
52周最低
4.75
市盈率
-6.98
股息
0.00
股息收益率
0.00
ROA
-26.73%
分时
五日
日K
周K
月K
暂无数据
北京优虎网络科技有限公司
资讯
新帖
简况
赛诺菲宣布16亿美元收购!
生物制品圈 · 07-26
赛诺菲宣布16亿美元收购!
呼吸道疫苗市场前景诱人!该头部药企宣布16亿美元收购
制药网 · 07-23
呼吸道疫苗市场前景诱人!该头部药企宣布16亿美元收购
加载更多
公司概况
公司名称:
Icosavax, Inc.
所属市场:
NASDAQ
上市日期:
2021-07-29
主营业务:
Icosavax, Inc.于2017年11月1日在特拉华州注册成立。该公司是一家生物制药公司,利用创新的病毒样颗粒(VLP)平台技术开发针对传染病的疫苗,最初的重点是威胁生命的呼吸系统疾病。该公司的VLP平台技术旨在实现复杂病毒抗原的多价、基于颗粒的显示,该公司相信这将诱导针对特定目标病毒的广泛、强大和持久的保护。该公司的产品包括针对一些最常见的肺炎病毒性病因的候选疫苗。该公司正在为老年人开发这些候选药物,这是一个有很高需求未得到满足的患者群体。该公司的主要候选疫苗IVX-A12是一种二价候选疫苗,或两种不同VLP候选疫苗的混合物。
发行价格:
15.00
{"stockData":{"symbol":"ICVX","market":"US","secType":"STK","nameCN":"Icosavax, Inc.","latestPrice":15.31,"timestamp":1708117200000,"preClose":15.31,"halted":3,"volume":0,"delay":0,"floatShares":29720875,"shares":50802709,"eps":-2.19469,"marketStatus":"停牌","change":0,"latestTime":"07-29 11:00:47 EDT","open":15.31,"high":15.31,"low":15.31,"amount":142682289.453564,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-2.19469,"tradingStatus":2,"nextMarketStatus":{"tag":"盘后交易","tradingStatus":3,"beginTime":1753819200000},"marketStatusCode":2,"adr":0,"listingDate":1627531200000,"exchange":"NASDAQ","adjPreClose":15.31,"volumeRatio":0},"requestUrl":"/m/hq/s/ICVX","defaultTab":"news","newsList":[{"id":"2554171521","title":"赛诺菲宣布16亿美元收购!","url":"https://stock-news.laohu8.com/highlight/detail?id=2554171521","media":"生物制品圈","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2554171521?lang=zh_cn&edition=full","pubTime":"2025-07-26 15:33","pubTimestamp":1753515229,"startTime":"0","endTime":"0","summary":"赛诺菲公司日前宣布,将以高达 16 亿美元的价格收购英国生物技术公司 Vicebio Ltd. 。根据协议,赛诺菲将预先支付 11.5 亿美元,后续若某些关键节点达成协议,还将支付高达 4.5 亿美元的额外款项。此次收购进一步巩固了赛诺菲在呼吸道病毒疫苗市场的布局,推动其更接近研发出新一代能在一次注射中为人体提供对多种呼吸道病毒防护的疫苗。此外,今年 2 月,阿斯利康曾以 11 亿美元收购了 Icosavax 。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726154144a4647176&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20250726154144a4647176&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["IE00B19Z3B42.SGD","BK4585","LU0985481810.HKD","IE000M9KFDE8.USD","IE00BLSP4452.SGD","SG9999011175.SGD","LU1066051498.USD","BK4139","BK4550","LU0321505868.SGD","SG9999002232.USD","LU0234572021.USD","LU0321505439.SGD","LU0456855351.SGD","LU0289739699.SGD","BK4581","IE00BLSP4239.USD","LU0058720904.USD","BK4534","BK4007","IE00BBT3K403.USD","LU0225771236.USD","LU0306807586.USD","LU1023059063.AUD","LU1894683264.USD","LU1066053197.SGD","IE0002270589.USD","BK4588","BK4599","LU0225284248.USD","SG9999002224.SGD","BK4533","SG9999003800.SGD","BK4539","BK4568","LU1057294990.SGD","BK4592","LU1894683348.USD","SG9999001176.SGD","LU0170899867.USD","LU0306806265.USD","SG9999013999.USD","LU0868494617.USD","VLP","IE00B19Z3581.USD","ICVX","LU1883839398.USD","LU0122379950.USD","SG9999001176.USD"],"gpt_icon":1},{"id":"2553291218","title":"呼吸道疫苗市场前景诱人!该头部药企宣布16亿美元收购","url":"https://stock-news.laohu8.com/highlight/detail?id=2553291218","media":"制药网","labels":["merge"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2553291218?lang=zh_cn&edition=full","pubTime":"2025-07-23 14:35","pubTimestamp":1753252549,"startTime":"0","endTime":"0","summary":"近期,制药企业在呼吸道疫苗市场动作频频,展现出对该领域的高度重视与大力投入。如2025 年 7 月 22 日,赛诺菲公司宣布,将以高达 16 亿美元的价格收购英国生物技术公司 Vicebio Ltd. 。此次收购进一步巩固了赛诺菲在呼吸道病毒疫苗市场的布局,推动其更接近研发出新一代能在一次注射中为人体提供对多种呼吸道病毒防护的疫苗。分析指出,呼吸道疾病的高发性和严重性是制药企业加大投入的重要原因。从市场前景来看,呼吸道疫苗市场潜力巨大。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072314383697b1eb62&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2025072314383697b1eb62&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"merge","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["MRK","ICVX","JNJ","GSK.UK","BK4539","LU1829250122.USD","BK4139","BK4532","BK4588","BK4585","GSK","AZN","VLP","BK4007"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.icosavax.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.013},{"period":"1month","weight":0.0358},{"period":"3month","weight":0.149},{"period":"6month","weight":0.0584},{"period":"1year","weight":0.1699},{"period":"ytd","weight":0.0868}],"compareStock":{"symbol":"SPY","name":"标普500ETF"},"description":"Icosavax, Inc.于2017年11月1日在特拉华州注册成立。该公司是一家生物制药公司,利用创新的病毒样颗粒(VLP)平台技术开发针对传染病的疫苗,最初的重点是威胁生命的呼吸系统疾病。该公司的VLP平台技术旨在实现复杂病毒抗原的多价、基于颗粒的显示,该公司相信这将诱导针对特定目标病毒的广泛、强大和持久的保护。该公司的产品包括针对一些最常见的肺炎病毒性病因的候选疫苗。该公司正在为老年人开发这些候选药物,这是一个有很高需求未得到满足的患者群体。该公司的主要候选疫苗IVX-A12是一种二价候选疫苗,或两种不同VLP候选疫苗的混合物。","exchange":"NASDAQ","name":"Icosavax, Inc.","nameEN":"Icosavax, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.34.4","shortVersion":"4.34.4","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Icosavax, Inc.(ICVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供Icosavax, Inc.(ICVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"Icosavax, Inc.,ICVX,Icosavax, Inc.股票,Icosavax, Inc.股票老虎,Icosavax, Inc.股票老虎国际,Icosavax, Inc.行情,Icosavax, Inc.股票行情,Icosavax, Inc.股价,Icosavax, Inc.股市,Icosavax, Inc.股票价格,Icosavax, Inc.股票交易,Icosavax, Inc.股票购买,Icosavax, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Icosavax, Inc.(ICVX)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供Icosavax, Inc.(ICVX)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}